Inhaltsverzeichnis
Anzeigen
New Hepatitis C Regimen Stimulates Changes in Therapy Management
Costly protease inhibitors work well in many patients, but call for careful monitoring
NEWS & COMMENTARY
UnitedHealthcare’s VP for oncology says it will take time to come to grips with the cost of chemotherapy, but we have to start now
We look at a few programs designed to address adherence-related behavioral problems
Although three pilot programs came up short, experts say systems like PROMETHEUS could still succeed — if plan medical directors take an active role
COVER STORY
Now that we know there is so much unwarranted deviation in care, payers are promoting comparative effectiveness research and other efforts to help providers embrace the evidence
EVIDENCE REVIEW
A summary of the ECRI Institute’s Emerging Technology Evidence Report
COMPENSATION MONITOR
EDITOR’S MEMO
LEGISLATION & REGULATION
However, they’ll need to prove it. Powerful interest groups say insurers have little experience with these patients and worry that MCOs will shortchange members.
MANAGED CARE OUTLOOK
PLAN WATCH
Healthy Blue Living in Michigan lets employers and members reap the benefits of lifestyle improvement
THE FORMULARY FILES
TOMORROW’S MEDICINE
Clinicians can consider this radiotherapy a viable treatment option
VIEWPOINT
Weighing the risks and benefits of any treatment to decide whether it is worth pursuing takes a kind of knowledge that most in health care lack
NEWS & COMMENTARY
NEWS & COMMENTARY
NEWS & COMMENTARY
NEWS & COMMENTARY
NEWS & COMMENTARY
Paul Lendner ist ein praktizierender Experte im Bereich Gesundheit, Medizin und Fitness. Er schreibt bereits seit über 5 Jahren für das Managed Care Mag. Mit seinen Artikeln, die einen einzigartigen Expertenstatus nachweisen, liefert er unseren Lesern nicht nur Mehrwert, sondern auch Hilfestellung bei ihren Problemen.